FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an …

“The approval of Mounjaro is an exciting step forward for people living with type 2 diabetes given the results seen in these clinical trials.”.

Read more at www.cardiovascularbusiness.com

Show More

Related Articles

Back to top button